Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement

Author:

Pasceri Vincenzo1ORCID,Pelliccia Francesco2,Mehran Roxana3ORCID,Dangas George3ORCID,Porto Italo45ORCID,Radico Francesco6ORCID,Biancari Fausto7ORCID,D'Ascenzo Fabrizio8ORCID,Saia Francesco9ORCID,Luzi Giampaolo10ORCID,Bedogni Francesco11,Amat Santos Ignacio J.12ORCID,De Marzo Vincenzo456,Dimagli Arnaldo13ORCID,Mäkikallio Timo7ORCID,Stabile Eugenio10,Blasco‐Turrión Sara12ORCID,Testa Luca11ORCID,Barbanti Marco14ORCID,Tamburino Corrado15ORCID,Fabiocchi Franco1617,Chilmeran Ahmed18,Conrotto Federico8,Costa Giuliano15ORCID,Stefanini Giulio19ORCID,Spaccarotella Carmen20,Macchione Andrea45,La Torre Michele8,Bendandi Francesco9ORCID,Juvonen Tatu21,Wańha Wojciech22ORCID,Wojakowski Wojtek22ORCID,Benedetto Umberto23,Indolfi Ciro20ORCID,Hildick‐Smith David18ORCID,Zimarino Marco624ORCID

Affiliation:

1. San Filippo Neri Hospital Rome Italy

2. Department of Cardiovascular Sciences University Sapienza Rome Italy

3. Icahn School of Medicine at Mount Sinai New York NY

4. Chair of Cardiovascular Disease, Department of Internal Medicine and Specialties University of Genoa Italy

5. Cardiology Unit, Cardiothoracic and Vascular Department (DICATOV) IRCCS Ospedale Policlinico San Martino Genoa Italy

6. Department of Cardiology ASL2 Abruzzo Chieti Italy

7. Department of Medicine South Karelia Central Hospital, University of Helsinki Lappeenranta Finland

8. Department of Internal Medicine Città della Salute e della Scienza Turin Italy

9. Department of Cardiothoracic Vascular Surgery University Hospital Bologna Italy

10. Cardiovascular Department Azienda Ospedaliera Regionale “San Carlo” Potenza Italy

11. Department of Cardiology IRCCS Policlinico San Donato, San Donato Milanese Milan Italy

12. CIBERCV, Interventional Cardiology Hospital Clínico Universitario de Valladolid Valladolid Spain

13. Department of Cardiothoracic Surgery Weill Cornell Medicine New York NY

14. Università degli Studi di Enna “Kore” Enna Italy

15. Division of Cardiology A.O.U. Policlinico “G. Rodolico—San Marco” Catania Italy

16. Centro Cardiologico Monzino, IRCCS Milan Italy

17. Galeazzi‐Sant’Ambrogio Hospital, I.R.C.C.S Milan Italy

18. Department of Cardiology Royal Sussex County Hospital Brighton UK

19. IRCCS Humanitas Research Hospital Rozzano‐Milan Italy

20. Division of Cardiology University Magna Graecia Catanzaro Italy

21. Heart and Lung Center, Helsinki University Central Hospital University of Helsinki Finland

22. Division of Cardiology and Structural Heart Diseases Medical University of Silesia Katowice Poland

23. Department of Cardiac Surgery University “G. d’Annunzio” Chieti Italy

24. Department of Neuroscience, Imaging and Clinical Sciences ‘G. D’Annunzio’ University of Chieti‐Pescara Italy

Abstract

Background Dialysis is a rare but serious complication after transcatheter aortic valve replacement. We analyzed the large multicenter TRITAVI (transfusion requirements in transcatheter aortic valve implantation) registry in order to develop and validate a clinical score assessing this risk. Methods and Results A total of 10 071 consecutive patients were enrolled in 19 European centers. Patients were randomly assigned (2:1) to a derivation and validation cohort. Two scores were developed, 1 including only preprocedural variables (TRITAVIpre) and 1 also including procedural variables (TRITAVIpost). In the 6714 patients of the derivation cohort (age 82±6 years, 48% men), preprocedural factors independently associated with dialysis and included in the TRITAVIpre score were male sex, diabetes, prior coronary artery bypass graft, anemia, nonfemoral access, and creatinine clearance <30 mL/min per m 2 . Additional independent predictors among procedural features were volume of contrast, need for transfusion, and major vascular complications. Both scores showed a good discrimination power for identifying risk for dialysis with C‐statistic 0.78 for TRITAVIpre and C‐statistic 0.88 for TRITAVIpost score. Need for dialysis increased from the lowest to the highest of 3 risk score groups (from 0.3% to 3.9% for TRITAVIpre score and from 0.1% to 6.2% for TRITAVIpost score). Analysis of the 3357 patients of the validation cohort (age 82±7 years, 48% men) confirmed the good discrimination power of both scores (C‐statistic 0.80 for TRITAVIpre and 0.81 for TRITAVIpost score). Need for dialysis was associated with a significant increase in 1‐year mortality (from 6.9% to 54.4%; P =0.0001). Conclusions A simple preprocedural clinical score can help predict the risk of dialysis after transcatheter aortic valve replacement.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3